X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (163) 163
male (103) 103
female (102) 102
adult (98) 98
obesity (83) 83
index medicus (81) 81
middle aged (78) 78
endocrinology & metabolism (66) 66
insulin resistance (63) 63
bariatric surgery (53) 53
surgery (53) 53
diabetes (48) 48
glucose (47) 47
insulin (44) 44
human necessities (39) 39
hygiene (39) 39
medical or veterinary science (39) 39
nutrition & dietetics (38) 38
preparations for medical, dental, or toilet purposes (38) 38
type 2 diabetes (38) 38
biliopancreatic diversion (37) 37
obesity, morbid - surgery (36) 36
specific therapeutic activity of chemical compounds ormedicinal preparations (36) 36
blood glucose - metabolism (35) 35
research (34) 34
weight loss (33) 33
metabolism (31) 31
risk factors (31) 31
weight-loss (31) 31
body mass index (30) 30
insulin - metabolism (30) 30
insulin - blood (29) 29
body composition (26) 26
insulin-resistance (26) 26
care and treatment (25) 25
health aspects (24) 24
animals (23) 23
insulin secretion (23) 23
resistance (23) 23
gastric bypass (22) 22
gastrointestinal surgery (22) 22
dextrose (21) 21
insulin resistance - physiology (21) 21
foods or foodstuffs (19) 19
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (19) 19
glucose - metabolism (19) 19
insulin sensitivity (19) 19
preservation of foods or foodstuffs, in general (19) 19
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (19) 19
their treatment, not covered by other classes (19) 19
abridged index medicus (18) 18
acyclic or carbocyclic compounds (18) 18
beta-cell function (18) 18
chemistry (18) 18
glucose clamp technique (18) 18
medicine & public health (18) 18
metallurgy (18) 18
organic chemistry (18) 18
secretion (18) 18
treatment outcome (18) 18
analysis (17) 17
diabetes mellitus, type 2 - surgery (17) 17
follow-up studies (17) 17
energy metabolism (16) 16
models, biological (16) 16
obesity - surgery (16) 16
physiological aspects (16) 16
sensitivity (16) 16
glucose metabolism (15) 15
glucose tolerance test (15) 15
aged (14) 14
diabetes mellitus (14) 14
blood glucose - analysis (13) 13
fatty acids, nonesterified - blood (13) 13
kinetics (13) 13
obesity, morbid - metabolism (13) 13
weight control (13) 13
y gastric bypass (13) 13
body weight (12) 12
diabetes mellitus, type 2 - complications (12) 12
diabetes mellitus, type 2 - metabolism (12) 12
disease (12) 12
medical therapy (12) 12
medicine, general & internal (12) 12
mellitus (12) 12
obesity - metabolism (12) 12
obesity - physiopathology (12) 12
oxidation (12) 12
physiology (12) 12
rats (12) 12
adipose tissue - metabolism (11) 11
adolescent (11) 11
calorimetry, indirect (11) 11
gastroenterology & hepatology (11) 11
leptin - blood (11) 11
obese-patients (11) 11
obesity, morbid - complications (11) 11
usage (11) 11
diabetes mellitus, type 2 - blood (10) 10
diabetes-mellitus (10) 10
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (324) 324
French (10) 10
German (8) 8
Chinese (3) 3
Spanish (3) 3
Danish (2) 2
Italian (2) 2
Portuguese (2) 2
Greek (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


LANCET, ISSN 0140-6736, 03/1997, Volume 349, Issue 9052, pp. 660 - 660
Journal Article
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 07/2019, Volume 7, Issue 7, pp. 504 - 505
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2012, Volume 366, Issue 17, pp. 1577 - 1585
Journal Article
Diabetologia, ISSN 0012-186X, 12/2018, Volume 61, Issue 12, pp. 2461 - 2498
The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the prior position statements, published in... 
Heart failure | Costs | Weight management | Human Physiology | Patient-centred care | Glucose-lowering therapy | Hypoglycaemia | Metabolic Diseases | Internal Medicine | Cardiovascular disease | Chronic kidney disease | Type 2 diabetes mellitus | Guidelines | Medicine & Public Health | MULTIPLE DAILY INJECTIONS | FIXED-RATIO COMBINATION | COTRANSPORTER 2 INHIBITORS | GLARGINE PLUS LIXISENATIDE | RANDOMIZED CONTROLLED-TRIAL | PEPTIDE-1 RECEPTOR AGONISTS | CLINICAL-PRACTICE GUIDELINES | DIPEPTIDYL PEPTIDASE-4 INHIBITORS | ENDOCRINOLOGY & METABOLISM | INTENSIVE MEDICAL THERAPY | CARDIOVASCULAR RISK-FACTORS | Hypoglycemic Agents - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | United States | Cardiovascular Diseases - drug therapy | Europe | Humans | Hyperglycemia - drug therapy | Consensus | Heart Failure - drug therapy | Renal Insufficiency, Chronic - drug therapy | Liraglutide - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide-1 Receptor - agonists | Insulin - therapeutic use | Type 2 diabetes | Hyperglycemia | Chronic kidney failure | Cardiac patients | Self-care, Health | Glucose | Business education | Dextrose | Diabetes therapy | Glucagon | Diabetes mellitus | Body weight loss | Management | Coronary artery disease | Sodium | Arteriosclerosis | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent) | Heart diseases | Glucagon-like peptide 1
Journal Article
Lancet Diabetes & Endocrinology, The, ISSN 2213-8587, 2017, Volume 5, Issue 3, pp. 152 - 154
Journal Article